Page 169 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P0283 ADENOSINE MONOPHOSPHATE ACTIVATED KINASE ePOSTERS
YI P0284 (AMPK) IN CANCER AND HUMAN HEPATIC STELLATE
YI P0285 CELL CROSSTALK
Katrin Schölzel*, Lisa Longato, Hazel Hummels, Brian Davidson,
YI P0286 Kevin Moore, Massimo Pinzani, Krista Rombouts, The United Kingdom
YI P0287
YI P0288 TYPE 2 DIABETES PROMOTES HEPATOCARCINOGENESIS
BY INHIBITING THE INDUCTION OF SENESCENCE AFTER
DNA DAMAGE
Miao Lu*, Norbert Hüser, Daniel Hartmann, Helmut Friess, Jörg Kleeff,
Yoshiaki Sunami, Germany

INACTIVATION OF CYCLIN E1 ACTS PRO-APOPTOTIC AND
ANTI-PROLIFERATIVE IN PRIMARY HEPATOMA CELLS
AND PROTECTS FROM HEPATOCARCINOGENESIS IN MICE
Roland Sonntag*, Nives Moro,Yulia A. Nevzorova, Jörg M. Bangen,
Dirk Fahrenkamp, Daniela Lambertz, Wei Hu, Nikolaus Gassler,
Gerhard Müller-Newen, Ralf Weiskirchen, Mariano Barbacid,
Peter Sicinski, Christian Trautwein, Christian Liedtke, Germany

C-MET SIGNALING CONTRIBUTES TO CARCINOGENESIS
OF CHOLANGIOCARCINOMA AND IS BLOCKED BY
LY2801653, A SMALL MOLECULE INHIBITOR
Samarpita Barat, Przemyslaw Bozko, Xi Chen, Tim Scholta,
Franziska Hanert, Julian Götze, Nisar Malek, Ludwig Wilkens,
Ruben Plentz*, Germany

LIVER-SPECIFIC EXPRESSION OF HBS-AG LEADS TO A
SHIFT OF TUMOR DIFFERENTIATION IN TRP53-DELETED
LIVER TUMORS
Sarah-Fee Katz*, Umesh Tharehalli, Michael Svinarenko,
Peter Schirmacher, Thomas Seufferlein, André Lechel, Germany

CXCR4 INHIBITION REVERTS IMMUNOSUPPRESSIVE
TUMOR MICROENVIRONMENT AND FACILITATES ANTI-
PD-1 IMMUNOTHERAPY IN SORAFENIB-TREATED
HEPATOCELLULAR CARCINOMA
Thomas Reiberger*, Chen Yunching, Rakesh R. Ramjiawan, Rosa R. Ng,
Tai Hato,Yuhui Huang, Elizabeth C. Unan, Tejaswini P. Reddy,
Christopher Fan, Peigen Huang, Nabeel Bardeesy, Andrew X. Zhu,
Rakesh K. Jain, Dan G. Duda, Austria

Vienna, Austria • April 22–26, 2015 169